CD151, CD81 and (Alpha)3(Beta)1 Integrin Function in Neurite Outgrowth

Total Page:16

File Type:pdf, Size:1020Kb

CD151, CD81 and (Alpha)3(Beta)1 Integrin Function in Neurite Outgrowth Journal of Cell Science 113, 1871-1882 (2000) 1871 Printed in Great Britain © The Company of Biologists Limited 2000 JCS1409 Transmembrane-4-superfamily proteins CD151 and CD81 associate with α3β1 integrin, and selectively contribute to α3β1-dependent neurite outgrowth Christopher S. Stipp and Martin E. Hemler* Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA *Author for correspondence (e-mail: [email protected]) Accepted 22 March; published on WWW 10 May 2000 SUMMARY Proteins in the transmembrane-4-superfamily (TM4SF) number, length, and rate of extension were all affected by form many different complexes with proteins in the anti-TM4SF antibodies. In summary: (1) these substrate- integrin family, but the functional utility of these complexes dependent inhibition results strongly suggest that CD151 has not yet been demonstrated. Here we show that TM4SF and CD81 associations with α3β1 are functionally relevant, proteins CD151, CD81, and CD63 co-distribute with α3β1 (2) TM4SF proteins CD151 and CD81 make a strong integrin on neurites and growth cones of human NT2N positive contribution toward neurite number, length, and cells. Also, stable CD151-α3β1 and CD81-α3β1 complexes rate of outgrowth, and (3) NT2N cells, a well-established were recovered in NT2N detergent lysates. Total NT2N model of immature central nervous system neurons, can be neurite outgrowth on laminin-5 (a ligand for α3β1 integrin) a powerful system for studies of integrin function in neurite was strongly inhibited by anti-CD151 and -CD81 outgrowth and growth cone motility. antibodies either together (~85% inhibition) or alone (~45% inhibition). Notably, these antibodies had no inhibitory effect on NT2N neurites formed on laminin-1 or Key words: Integrin, Transmembrane-4-superfamily, Neuron, fibronectin, when α3β1 integrin was not engaged. Neurite Neurite, Laminin-5 INTRODUCTION example, α3β1-CD151 association is selectively maintained in 1% Triton X-100; additional interactions of α3β1 and α6β1 TM4SF proteins (also called tetraspanins) are present at with TM4SF proteins are selectively seen in 1% Brij-96 reasonably high levels on nearly every mammalian cell detergent; and many other integrin-TM4SF interactions are and tissue type. There are at least 21 core family members seen only in less stringent detergent conditions (e.g. 1% (Hemler et al., 1996; Maecker et al., 1997; Todd et al., 1998; CHAPS). Wright and Tomlinson, 1994), each containing 4 presumed The role of integrins during cell adhesion and motility is well transmembrane domains, short N- and C-terminal cytoplasmic established (Huttenlocher et al., 1995; Sheetz et al., 1998). domains (containing 5-14 amino acids), a small intracellular TM4SF proteins likewise regulate cell motility, although they loop (typically 4 aa), and two extracellular loops (20-27 aa; 75- generally do not participate in cell adhesion (Hemler, 1998; 130 aa). Maecker et al., 1997). Thus it seems likely that integrin- Like TM4SF proteins, proteins in the integrin family of cell TM4SF protein complexes might play a role in cell motility. adhesion receptors are widespread on many cell types (Hynes Indeed, sometimes in the same experiment, antibodies to both and Lander, 1992). Notably, the α2β1, α3β1, α4β1, α4β7, integrins and TM4SF proteins (CD81, CD151, CD9, CD63) α5β1, α6β1, α6β4, αIIbβ3, and αLβ2 integrins have all been inhibited cell motility (Sincock et al., 1999; Yanez-Mo et al., suggested to associate with various TM4SF proteins including 1998; Yauch et al., 1998). However, in those studies the issue CD9, CD63, CD81, CD82, and/or CD151 (Berditchevski et al., of integrin substrate specificity was not addressed, and it was 1995; Fitter et al., 1999; Hadjiargyrou et al., 1996; Hasegawa not clear the extent to which the integrin-TM4SF proteins et al., 1998; Hemler, 1998; Hemler et al., 1996; Jones et al., complexes needed to be actively engaged on integrin ligand. In 1996; Nakamura et al., 1995; Rubinstein et al., 1994; Schmidt fact, another study has specifically demonstrated that α6Aβ1 et al., 1996; Sincock et al., 1999; Skubitz et al., 1996; Yanez- integrin can induce CD81-dependent motility without Mo et al., 1998; Yauch et al., 1998). However, detection of obviously engaging the integrin substrate (Domanico et al., integrin-TM4SF protein interactions varies considerably 1997). depending on detergent conditions (Berditchevski et al., 1996; To address whether specific α3β1-TM4SF complexes might Serru et al., 1999; Sincock et al., 1999; Yauch et al., 1998). For be functionally relevant, we have chosen to study NT2N cells. 1872 C. S. Stipp and M. E. Hemler NT2N cells are neuron-like cells derived from the human NT2 integrin cytoplasmic domain (Takada and Hemler, 1989); an embryonic carcinoma cell line (Pleasure et al., 1992). These antiserum raised against intact, denatured β4 integrin (unpublished), cells express many integrins and TM4SF proteins for which and horseradish peroxidase (HRP)-conjugated goat-anti-mouse and antibodies are available, and thus had a strong potential to goat anti-rabbit antibodies (Sigma). provide insight into the roles of TM4SF proteins in neurite Cell culture outgrowth and growth cone motility. In addition, NT2N α β NT2 precursor cells (Stratagene) were maintained in OPTI-MEM neurites grew on many different substrates, including the 3 1 (Gibco-BRL) with 10% fetal bovine serum, penicillin-streptomycin, ligand laminin-5, thus allowing an evaluation of the substrate- and 2 mM glutamine. NT2N neuron-like cells were obtained as dependent inhibitory effects of anti-TM4SF antibodies. described by Pleasure et al. (1992). Briefly, NT2 precursor cells were The roles of TM4SF proteins themselves, or of integrin- treated with 10 µm retinoic acid for 4-5 weeks then split 1:6 into TM4SF complexes during neurite outgrowth have not been medium with mitotic inhibitors and cultured an additional 10-14 days. studied, except for a few reports involving the CD9 protein. In NT2N cells, growing as clusters over a monolayer of non-neuronal one case, CD9 associated with integrin α6β1 under conditions cells, were isolated by rinsing with phosphate-buffered saline (PBS) of relatively low detergent stringency, and anti-CD9 antibody and treating for 2-3 minutes with trypsin/EDTA diluted 30-fold in stimulated neurite outgrowth of small cerebellar neurons on PBS. Purified neurons were maintained on plates coated with Matrigel (Becton Dickinson) diluted 1:50. laminin-1, but not poly-L-lysine (Schmidt et al., 1996). α β Since the exact number of clustered NT2N cells in a culture is However, the functional role of 6 1 was not elucidated. In difficult to determine, NT2N cell purity was estimated as follows: another study, immobilized anti-CD9 antibody supported morphologically non-neuronal cells in 20 random fields were counted, neurite outgrowth from sympathetic neurons, which was partly and the amount of detergent extractable protein contributed by these inhibited by anti-α3β1 mAb (Banerjee et al., 1997). However, cells was calculated using a value of protein/cell obtained from lysates because anti-α3 mAb also inhibited neurite outgrowth on of known numbers of NT2 precursor cells. The protein derived from immobilized anti-Thy1 mAb and on collagen (Banerjee et al., non-neuronal cells was then expressed as a fraction of the total protein 1997), the specific functional involvement of α3β1-CD9 obtained from the NT2N cell lysates, and found to be less than 1% of complexes was not clear. Thus far, antibodies to TM4SF the total. For neurite outgrowth and staining experiments, NT2N cells were proteins had not been shown to inhibit neurite outgrowth. rinsed with PBS and treated with trypsin/EDTA diluted 10-fold in Here we show for the first time strong inhibition of neurite PBS. Cells were dislodged, and trypsin treatment was stopped by outgrowth by antibodies to TM4SF proteins (in this case, adding DME with 5 mg/ml crystalline bovine serum albumin (BSA) CD151 and CD81). Furthermore, we show inhibition by anti- (ICN) and 0.2 mg/ml soybean trypsin inhibitor (Sigma). Cells were TM4SF antibodies that depends on functional engagement of collected by centrifugation, resuspended in a serum-free medium TM4SF-associated α3β1 integrin with its laminin-5 ligand. consisting of DMEM with B27 additives (Brewer et al., 1993), (Gibco Such integrin-substrate dependence had not been previously BRL) and 1 mM glutamine, and plated to substrate-coated coverslips. demonstrated in studies of integrin-TM4SF complexes on Preparation of coverslips; video-microscopy neurons or other cell types. Together these results strongly Acid-washed glass coverslips were coated with 20 µg/ml mouse suggest that integrin-TM4SF complexes can act as a functional laminin-1 (Gibco BRL), diluted in PBS, with 2 µg/ml rat laminin-5 unit, dependent on integrin engagement with ligand, and of (a gift of Desmos Inc.) diluted in PBS with 0.005% Tween-20, or with critical importance during neurite outgrowth. During the 20 µg/ml fibronectin (Becton-Dickinson). Substrates were coated course of these studies we also show that NT2N cell either for 1 hour at 37°C or overnight at 4°C. Coverslips were rinsed differentiation is accompanied by pronounced changes in 3 times in PBS and blocked with 10 mg/ml heat-inactivated BSA for integrin and TM4SF protein expression, and that NT2/NT2N 1 hour at 37°C. Coverslips were rinsed three times and used for cells are an excellent system for studying human neurite experiments described below. differentiation and outgrowth. Video images were acquired using a Zeiss Axiovert 135 microscope equipped with (1) a VS25 electronic shutter driven by a Uniblitz D122 controller (Vincent Associates) and (2) a black and white video camera (TM-7AS, PULNiX America Inc.) connected via a focusing MATERIALS AND METHODS monitor (PVM-137, Sony Corp.) to a Power Macintosh 6500 computer containing a VG-5 frame grabber (Scion Corp.). Image Antibodies acquisition was performed with the program Scion Image 1.60 (Scion Anti-integrin mAbs used were anti-α1, TS2/7 (Hemler et al., 1984), Corp.).
Recommended publications
  • RI-Mediated Mast Cell Activation Ε of Fc Tetraspanin CD151 Is A
    Tetraspanin CD151 Is a Negative Regulator of Fc εRI-Mediated Mast Cell Activation Hiam Abdala-Valencia, Paul J. Bryce, Robert P. Schleimer, Joshua B. Wechsler, Lucas F. Loffredo, Joan M. Cook-Mills, This information is current as Chia-Lin Hsu and Sergejs Berdnikovs of September 26, 2021. J Immunol 2015; 195:1377-1387; Prepublished online 1 July 2015; doi: 10.4049/jimmunol.1302874 http://www.jimmunol.org/content/195/4/1377 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2015/07/01/jimmunol.130287 Material 4.DCSupplemental http://www.jimmunol.org/ References This article cites 63 articles, 28 of which you can access for free at: http://www.jimmunol.org/content/195/4/1377.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Tetraspanin CD151 Is a Negative Regulator of Fc«RI-Mediated Mast Cell Activation Hiam Abdala-Valencia,* Paul J.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Dynamics Within Tetraspanin Pairs Affect MHC Class II Expression
    328 Research Article Dynamics within tetraspanin pairs affect MHC class II expression Tineke van den Hoorn, Petra Paul, Lennert Janssen, Hans Janssen and Jacques Neefjes* Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands *Author for correspondence ([email protected]) Accepted 11 August 2011 Journal of Cell Science 125, 328–339 ß 2012. Published by The Company of Biologists Ltd doi: 10.1242/jcs.088047 Summary Late endosomal multivesicular bodies (MVBs) are complicated organelles with various subdomains located at the limiting membrane and the internal vesicles (ILVs). ILVs accumulate tetraspanins such as CD63 and CD82 that might form protein assemblies, including major histocompatibility complex class II (MHC-II) and its chaperone human leukocyte antigen (HLA)-DM. Here, we studied the effect of four late endosomal tetraspanin proteins on MHC-II expression. Silencing CD9, CD63 and CD81 enhanced MHC-II expression whereas silencing CD82 did not. No effect on peptide loading was observed. Using confocal FRET technology, we measured the dynamics of CD63 and CD82 interaction with MHC-II and its chaperone HLA-DM. CD63–CD82 interactions remained unaltered in the two MVB subdomains whereas the interactions between CD63 or CD82 homologous pairs changed. CD63 stably associated with MHC- II, and CD82 with HLA-DM, on both MVB subdomains whereas the CD82–MHC-II and CD63–HLA-DM interactions changed. These data visualize for the first time the protein dynamics of tetraspanin assemblies in MVB
    [Show full text]
  • Systemic Induction of the Angiogenesis Switch by the Tetraspanin D6.1A/CO-029
    Research Article Systemic Induction of the Angiogenesis Switch by the Tetraspanin D6.1A/CO-029 Sabine Gesierich,1 Igor Berezovskiy,1 Eduard Ryschich,2 and Margot Zo¨ller1,3 1Department of Tumor Progression and Immune Defence, German Cancer Research Centre; 2Department of Surgery, University of Heidelberg, Heidelberg; and 3Department of Applied Genetics, Faculty of Chemistry and Bioscience, University of Karlsruhe, Karlsruhe, Germany Abstract transcription of angiogenic factors (6, 7). Recent studies in Expression of the tetraspanin CO-029 is associated with poor knockout and transgenic mouse models have provided further prognosis in patients with gastrointestinal cancer. In a evidence that tumor angiogenesis is not only guided by the pancreatic tumor line, overexpression of the rat homologue, tumor cell itself, but is also closely tied to the tumor microenvi- ronment (8). D6.1A, induces lethally disseminated intravascular coagula- tion, suggesting D6.1A engagement in angiogenesis. D6.1A- Tetraspanins are a large family of proteins grouped according to overexpressing tumor cells induce the greatest amount of structural relatedness. The key feature of tetraspanins is their angiogenesis in vivo, and tumor cells as well as exosomes potential to associate with each other and with a multitude of derived thereof strikingly increase endothelial cell branching molecules from other protein families (9–11), the most prominent in vitro. Tumor cell–derived D6.1A stimulates angiogenic partners being integrins (12). The tetraspanin, D6.1A (rat)/CO-029 a h a h factor transcription, which includes increased matrix metal- (human), associates with 3 1 and 6 1 and, after disassembly of a h loproteinase and urokinase-type plasminogen activator se- hemidesmosomes, with 6 4.
    [Show full text]
  • A Shared Pathway of Exosome Biogenesis Operates at Plasma And
    bioRxiv preprint doi: https://doi.org/10.1101/545228; this version posted February 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A shared pathway of exosome biogenesis operates at plasma and endosome membranes Francis K. Fordjour1, George G. Daaboul2, and Stephen J. Gould1* 1Department of Biological Chemistry Johns Hopkins University Baltimore, MD USA 2Nanoview Biosciences Boston, MA USA Corresponding author: Stephen J. Gould, Ph.D. Department of Biological Chemistry Johns Hopkins University Baltimore, MD USA Email: [email protected] Tel (01) 443 847 9918 1 bioRxiv preprint doi: https://doi.org/10.1101/545228; this version posted February 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary: This study of exosome cargo protein budding reveals that cells use a common pathway for budding exosomes from plasma and endosome membranes, providing a new mechanistic explanation for exosome heterogeneity and a rational roadmap for exosome engineering. Keywords: Protein budding, tetraspanin, endosome, plasma membrane, extracellular vesicle, CD9, CD63, CD81, SPIR, interferometry Abbreviations: EV, extracellular vesicles; IB, immunoblot; IFM, immunofluorescence microscopy; IPMC, intracellular plasma membrane-connected compartment; MVB, multivesicular body; SPIR, single-particle interferometric reflectance; SPIRI, single-particle interferometric reflectance imaging 2 bioRxiv preprint doi: https://doi.org/10.1101/545228; this version posted February 11, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved.
    [Show full text]
  • Expression of the Tetraspanins CD9, CD37, CD63, and CD151 in Merkel Cell Carcinoma: Strong Evidence for a Posttranscriptional Fine-Tuning of CD9 Gene Expression
    Modern Pathology (2010) 23, 751–762 & 2010 USCAP, Inc. All rights reserved 0893-3952/10 $32.00 751 Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression Markus Woegerbauer1, Dietmar Thurnher1, Roland Houben2, Johannes Pammer3, Philipp Kloimstein1, Gregor Heiduschka1, Peter Petzelbauer4 and Boban M Erovic1 1Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria; 2Department of Dermatology, Medical University of Wuerzburg, Germany; 3Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria and 4Department of Dermatology, Medical University of Vienna, Vienna, Austria Tetraspanins including CD9, CD37, CD63, and CD151 are linked to cellular adhesion, cell differentiation, migration, carcinogenesis, and tumor progression. The aim of the study was to detect, quantify, and evaluate the prognostic value of these tetraspanins in Merkel cell carcinoma and to study the regulation of CD9 mRNA expression in Merkel cell carcinoma cell lines in detail. Immunohistochemical staining of 28 Merkel cell carcinoma specimens from 25 patients showed a significant correlation of CD9 (P ¼ 0.03) and CD151 (P ¼ 0.043) expression to overall survival. CD9 and CD63 expression correlated significantly to patients’ disease-free interval (P ¼ 0.017 and P ¼ 0.058). Of primary Merkel cell carcinoma tumors, 42% were CD9 positive in contrast to only 21% of the subcutaneous in-transit metastases. Characterization of the 50 untranslated region (UTR) of the CD9 mRNA from two cultured Merkel cell carcinoma cell lines revealed the presence of two major RNA species differing only in the length of their 50 termini (183 versus 102 nucleotides).
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Kruppel-Like Factor 9 Inhibits Glioblastoma Stemness
    KRUPPEL-LIKE FACTOR 9 INHIBITS GLIOBLASTOMA STEMNESS THROUGH GLOBAL TRANSCRIPTION REPRESSION AND INHIBITION OF INTEGRIN ALPHA 6 AND CD151 By Jessica Tilghman A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland October, 2015 Abstract Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing novel strategies that target tumor propagation to inhibit cancer progression and improve patient survival. Krüppel-like factor 9 (KLF9) has emerged as a regulator of cell differentiation, neural development, and oncogenesis; however, the molecular basis for KLF9’s diverse contextual functions has been unclear. We establish for the first time a genome-wide map of KLF9-regulated targets in human glioblastoma stem-like cells, and show that KLF9 functions as a transcriptional repressor and thereby regulates multiple signaling pathways involved in oncogenesis and regulation of cancer stem-like phenotype. A detailed analysis of two novel KLF9 targets suggests that KLF9 inhibits glioma cell stemness by repressing expression of integrin α6 and CD151. The expression of one candidate KLF9 target gene ITGA6 coding for integrin α6 was verified to be downregulated by KLF9 in GSCs. ITGA6 transcription repression by KLF9 altered GBM neurosphere cell behavior as evidenced by reduced cell adhesion to and migration through membrane coated with the integrin α6 ligand laminin. Forced expression of integrin α6 partially rescued GBM neurosphere cells from the differentiating and adhesion/migration-inhibiting effects of KLF9.
    [Show full text]
  • Human Eosinophils and Their Activation by Allergens Via Danger
    Human eosinophils and their activation by allergens via danger signal receptors Elin Redvall ______________________ 2010 Department of Infectious diseases, Institute of Biomedicine, The Sahlgrenska Academy Cover illustration photo: Kerstin Andersson (Eosinophils) Abstract Human eosinophilic granulocytes are polymorphonuclear cells with a powerful arsenal of cytotoxic substances in their granules, which are mainly found in the gastrointestinal mucosa, and the respiratory and genitourinary tracts. Their physiological role is incompletely understood, although it is likely they protect the mucosal surfaces, perhaps by recognizing danger signals present on microorganisms or released from damaged tissue. We have earlier shown that eosinophils can recognize and become directly activated by aeroallergens such as house dust mite (HDM) and birch pollen. Eosinophils exposed to (HDM) release both of the cytotoxic granule proteins eosinophil peroxidase (EPO) and major basic protein, whereas birch pollen extract only triggers EPO release. Here we further investigate which receptors on eosinophils are used to signal the presence of HDM and birch pollen. Recognition was found to be mediated by the formyl peptide receptors (FPRs) FPR1 and FPR2. We also characterized the expression of this family of receptors in human eosinophils and found that they express FPR1 and FPR2, but not FPR3, similar to neutrophilic granulocytes. We also discovered that signaling through FPR1 can desensitize the eotaxin-1 receptor CCR3 rendering the cells anergic with respect to chemotaxis in response to eotaxin-1, but not regarding respiratory burst. Hence, there is cross- talk between these two receptors regarding one important effector function of eosinophils. Eosinophilic reactivity in vitro to the aeroallergens HDM, birch pollen, timothy grass pollen and cat dander did not differ between individuals with allergy and healthy individuals.
    [Show full text]
  • Tetraspanin CD151 Plays a Key Role in Skin Squamous Cell Carcinoma
    Oncogene (2013) 32, 1772–1783 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc ORIGINAL ARTICLE Tetraspanin CD151 plays a key role in skin squamous cell carcinoma QLi1, XH Yang2,FXu1, C Sharma1, H-X Wang1, K Knoblich1, I Rabinovitz3, SR Granter4 and ME Hemler1 Here we provide the first evidence that tetraspanin CD151 can support de novo carcinogenesis. During two-stage mouse skin chemical carcinogenesis, CD151 reduces tumor lag time and increases incidence, multiplicity, size and progression to malignant squamous cell carcinoma (SCC), while supporting both cell survival during tumor initiation and cell proliferation during the promotion phase. In human skin SCC, CD151 expression is selectively elevated compared with other skin cancer types. CD151 support of keratinocyte survival and proliferation may depend on activation of transcription factor STAT3 (signal transducers and activators of transcription), a regulator of cell proliferation and apoptosis. CD151 also supports protein kinase C (PKC)a–a6b4 integrin association and PKC-dependent b4 S1424 phosphorylation, while regulating a6b4 distribution. CD151–PKCa effects on integrin b4 phosphorylation and subcellular localization are consistent with epithelial disruption to a less polarized, more invasive state. CD151 ablation, while minimally affecting normal cell and normal mouse functions, markedly sensitized mouse skin and epidermoid cells to chemicals/drugs including 7,12-dimethylbenz[a]anthracene (mutagen) and camptothecin (topoisomerase inhibitor), as well as to agents targeting epidermal growth factor receptor, PKC, Jak2/Tyk2 and STAT3. Hence, CD151 ‘co-targeting’ may be therapeutically beneficial. These findings not only support CD151 as a potential tumor target, but also should apply to other cancers utilizing CD151/laminin-binding integrin complexes.
    [Show full text]
  • Pancancer Progression Human Vjune2017
    Gene Symbol Accession Alias/Prev Symbol Official Full Name AAMP NM_001087.3 - angio-associated, migratory cell protein ABI3BP NM_015429.3 NESHBP|TARSH ABI family, member 3 (NESH) binding protein ACHE NM_000665.3 ACEE|ARACHE|N-ACHE|YT acetylcholinesterase ACTG2 NM_001615.3 ACT|ACTA3|ACTE|ACTL3|ACTSG actin, gamma 2, smooth muscle, enteric ACVR1 NM_001105.2 ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI activin A receptor, type I ACVR1C NM_145259.2 ACVRLK7|ALK7 activin A receptor, type IC ACVRL1 NM_000020.1 ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I activin A receptor type II-like 1 ADAM15 NM_207195.1 MDC15 ADAM metallopeptidase domain 15 ADAM17 NM_003183.4 ADAM18|CD156B|CSVP|NISBD|TACE ADAM metallopeptidase domain 17 ADAM28 NM_014265.4 ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII ADAM metallopeptidase domain 28 ADAM8 NM_001109.4 CD156|MS2 ADAM metallopeptidase domain 8 ADAM9 NM_001005845.1 CORD9|MCMP|MDC9|Mltng ADAM metallopeptidase domain 9 ADAMTS1 NM_006988.3 C3-C5|METH1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 ADAMTS12 NM_030955.2 PRO4389 ADAM metallopeptidase with thrombospondin type 1 motif, 12 ADAMTS8 NM_007037.4 ADAM-TS8|METH2 ADAM metallopeptidase with thrombospondin type 1 motif, 8 ADAP1 NM_006869.2 CENTA1|GCS1L|p42IP4 ArfGAP with dual PH domains 1 ADD1 NM_001119.4 ADDA adducin 1 (alpha) ADM2 NM_001253845.1 AM2|dJ579N16.4 adrenomedullin 2 ADRA2B NM_000682.4 ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR adrenoceptor alpha 2B AEBP1 NM_001129.3 ACLP AE binding protein 1 AGGF1 NM_018046.3 GPATC7|GPATCH7|HSU84971|HUS84971|VG5Q
    [Show full text]
  • RT² Profiler PCR Array (Rotor-Gene® Format) Human Cell Surface Markers
    RT² Profiler PCR Array (Rotor-Gene® Format) Human Cell Surface Markers Cat. no. 330231 PAHS-055ZR For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Rotor-Gene Q, other Rotor-Gene cyclers Format R Description The Human Cell Surface Markers RT² Profiler PCR Array profiles the expression of 84 genes relevant to research at the cell surface marker level. These markers have been used in studies including: 1) determination of the extent of leukocyte infiltration among cancer tissues; 2) characterization of cell populations isolated from patients with chronic inflammatory diseases such as atherosclerosis, asthma, inflammatory bowel disease, and arthritis; 3) determination of T- and B-cell lineage and clonality; 4) characterization of leukocyte populations for use in the prognosis of disease stage and progression; and 5) analysis of the composition of immune infiltrates and their association with organ rejection. Using real-time PCR, you can easily and reliably analyze expression of a focused panel of genes related to cell surface markers with this array. For further details, consult the RT² Profiler PCR Array Handbook. Shipping and storage RT² Profiler PCR Arrays in the Rotor-Gene format are shipped at ambient temperature, on dry ice, or blue ice packs depending on destination and accompanying products. For long term storage, keep plates at –20°C. Note: Ensure that you have the correct RT² Profiler PCR Array format for your real-time cycler (see table above). Note: Open the package and store the products appropriately immediately on receipt. Sample & Assay Technologies Array layout The 96 real-time assays in the Rotor-Gene format are located in wells 1–96 of the Rotor-Disc™ (plate A1–A12=Rotor-Disc 1–12, plate B1–B12=Rotor-Disc 13–24, etc.).
    [Show full text]